Company · CIK 0001816736 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Disc Medicine, Inc. · IRON
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 16, 6:44 pm EDT | John D QuiselChief Executive Officer, Director | 36,000 | $1.01 | $36,360 | 262,064 | — | |
| Sep 11, 2026 SForm 4 → | Sep 15, 4:30 pm EDT | Kevin BittermanDirector | 27,136 | $70.11 | $1,902,505 | 0 | −100% | |
| Sep 11, 2026 MForm 4 → | Sep 15, 4:30 pm EDT | Kevin BittermanDirector | 27,136 | $45.07 | $1,223,144 | 27,136 | — | |
| Sep 4, 2026 SForm 4 → | Sep 9, 4:23 pm EDT | Kevin BittermanDirector | 1,689 | $79.96 | $135,052 | 13,427 | −11.2% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 5:43 pm EDT | Kevin BittermanDirector | 54,496 | $80.15 | $4,367,944 | 13,445 | −80.2% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 16, 6:44 pm EDT | John D QuiselChief Executive Officer, Director | 36,000 | — | — | 150,120 | — | |
| Sep 11, 2026 MForm 4 → | Sep 15, 4:30 pm EDT | Kevin BittermanDirector | 27,136 | — | — | 0 | — |